Tesamorelin: The High-Intensity Option Tesamorelin is a 44-amino acid synthetic analog of GHRH the full-length molecule with a trans-3-hexenoic acid modification that makes it more stable and resistant to enzymatic breakdown (specifically DPP-4 resistant)
In the evolving landscape of diabetes and obesity treatment, two medicationsTirzepatide and Retatrutide, are generating considerable attention
Mark Kennedy has received honoraria for serving as a speaker for and advisory board member of Eli Lilly
Also, lixisenatide OD had a neutral CV profile compared with placebo, but also did not increase the CV risk (Fig
However, patients require closer monitoring of hydration status, blood pressure, and renal function, as the combination may increase dehydration risk, particularly during gastrointestinal side effects or dose escalation periods
Rybelsus is for adults with type 2 diabetes as part of a program that includes healthy eating and activity